Literature DB >> 25232262

Heartburn and regurgitation have different impacts on life quality of patients with gastroesophageal reflux disease.

Shou-Wu Lee1, Han-Chung Lien1, Teng-Yu Lee1, Sheng-Shun Yang1, Hong-Jeh Yeh1, Chi-Sen Chang1.   

Abstract

AIM: To investigate the impact of heartburn and regurgitation on the quality of life among patients with gastroesophageal reflux disease (GERD).
METHODS: Data from patients with GERD, who were diagnosed according to the Montreal definition, were collected between January 2009 and July 2010. The enrolled patients were assigned to a heartburn or a regurgitation group, and further assigned to an erosive esophagitis (EE) or a non-erosive reflux disease (NERD) subgroup, depending on the predominant symptoms and endoscopic findings, respectively. The general demographic data, the scores of the modified Chinese version of the GERDQ and the Short-form 36 (SF-36) questionnaire scores of these groups of patients were compared.
RESULTS: About 108 patients were classified in the heartburn group and 124 in the regurgitation group. The basic characteristics of the two groups were similar, except for male predominance in the regurgitation group. Patients in the heartburn group had more sleep interruptions (22.3% daily vs 4.8% daily, P = 0.021), more eating or drinking problems (27.8% daily vs 9.7% daily, P = 0.008), more work interferences (11.2% daily vs none, P = 0.011), and lower SF-36 scores (57.68 vs 64.69, P = 0.042), than patients in the regurgitation group did. Individuals with NERD in the regurgitation group had more impaired daily activities than those with EE did.
CONCLUSION: GERD patients with heartburn or regurgitation predominant had similar demographics, but those with heartburn predominant had more severely impaired daily activities and lower general health scores. The NERD cases had more severely impaired daily activity and lower scores than the EE ones did.

Entities:  

Keywords:  Erosive esophagitis; Gastroesophageal reflux disease; Gender; Life quality; Non-erosive reflux disease

Mesh:

Year:  2014        PMID: 25232262      PMCID: PMC4161813          DOI: 10.3748/wjg.v20.i34.12277

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  18 in total

1.  An evidence-based appraisal of reflux disease management--the Genval Workshop Report.

Authors: 
Journal:  Gut       Date:  1999-04       Impact factor: 23.059

2.  The endoscopic assessment of esophagitis: a progress report on observer agreement.

Authors:  D Armstrong; J R Bennett; A L Blum; J Dent; F T De Dombal; J P Galmiche; L Lundell; M Margulies; J E Richter; S J Spechler; G N Tytgat; L Wallin
Journal:  Gastroenterology       Date:  1996-07       Impact factor: 22.682

3.  Health-related quality of life in primary care patients with gastroesophageal reflux disease.

Authors:  B Kaplan-Machlis; G E Spiegler; D A Revicki
Journal:  Ann Pharmacother       Date:  1999-10       Impact factor: 3.154

4.  Proximal stomach function in obesity with normal or abnormal oesophageal acid exposure.

Authors:  P Iovino; L Angrisani; G Galloro; D Consalvo; F Tremolaterra; A Pascariello; C Ciacci
Journal:  Neurogastroenterol Motil       Date:  2006-06       Impact factor: 3.598

5.  Gastroesophageal reflux symptoms and well-being in a random sample of the general population of a Swedish community.

Authors:  Ingela Wiklund; Jonas Carlsson; Nimish Vakil
Journal:  Am J Gastroenterol       Date:  2006-01       Impact factor: 10.864

Review 6.  Review of the quality of life and burden of illness in gastroesophageal reflux disease.

Authors:  Ingela Wiklund
Journal:  Dig Dis       Date:  2004       Impact factor: 2.404

7.  Relationship between Psychological Factors and Quality of Life in Subtypes of Gastroesophageal Reflux Disease.

Authors:  Jung-Hwan Oh; Tae-Suk Kim; Myung-Gyu Choi; Hyeug Lee; Eun-Jung Jeon; Sang-Wook Choi; Chul Lee; In-Sik Chung
Journal:  Gut Liver       Date:  2009-12-31       Impact factor: 4.519

8.  Impact of persistent, frequent regurgitation on quality of life in heartburn responders treated with acid suppression: a multinational primary care study.

Authors:  P J Kahrilas; C W Howden; B Wernersson; H Denison; J Nuevo; J P Gisbert
Journal:  Aliment Pharmacol Ther       Date:  2013-04-05       Impact factor: 8.171

9.  Relationship between symptom load of gastro-oesophageal reflux disease and health-related quality of life, work productivity, resource utilization and concomitant diseases: survey of a US cohort.

Authors:  P Wahlqvist; M Karlsson; D Johnson; J Carlsson; S C Bolge; M-A Wallander
Journal:  Aliment Pharmacol Ther       Date:  2008-02-29       Impact factor: 8.171

Review 10.  The association between obesity and GERD: a review of the epidemiological evidence.

Authors:  Hashem El-Serag
Journal:  Dig Dis Sci       Date:  2008-07-24       Impact factor: 3.199

View more
  12 in total

1.  Efficacy and tolerability of hydrogen carbonate-rich water for heartburn.

Authors:  André-Michael Beer; Ralf Uebelhack; Ute Pohl
Journal:  World J Gastrointest Pathophysiol       Date:  2016-02-15

2.  Health-related quality of life in gastroesophageal reflux patients with noncardiac chest pain: Emphasis on the role of psychological distress.

Authors:  Lei Zhang; Lei Tu; Jie Chen; Jun Song; Tao Bai; Xue-Lian Xiang; Rui-Yun Wang; Xiao-Hua Hou
Journal:  World J Gastroenterol       Date:  2017-01-07       Impact factor: 5.742

3.  Perceptions of patient-centered care among Veterans with gastroesophageal reflux disease on proton pump inhibitor therapy.

Authors:  Salva Balbale; Andrew Gawron; Sherri L LaVela
Journal:  Patient Exp J       Date:  2018

4.  Associations between obstructive sleep apnea severity and endoscopically proven gastroesophageal reflux disease.

Authors:  Youlim Kim; Yeon Joo Lee; Jong Sun Park; Young-Jae Cho; Ho Il Yoon; Jae Ho Lee; Choon-Taek Lee; Se Joong Kim
Journal:  Sleep Breath       Date:  2017-07-07       Impact factor: 2.816

5.  A randomized, crossover pharmacodynamic study of immediate-release omeprazole/sodium bicarbonate and delayed-release lansoprazole in healthy adult volunteers.

Authors:  Vijayalakshmi S Pratha; Thomas McGraw; William Tobin
Journal:  Pharmacol Res Perspect       Date:  2016-05-19

6.  Gender is a risk factor in patients with gastroesophageal reflux disease.

Authors:  Hashem Fakhre Yaseri
Journal:  Med J Islam Repub Iran       Date:  2017-09-08

7.  Antireflux mucosectomy band in treatment of refractory gastroesophageal reflux disease: a pilot study for safety, feasibility and symptom control.

Authors:  Laurent Monino; Jean-Michel Gonzalez; Véronique Vitton; Marc Barthet
Journal:  Endosc Int Open       Date:  2020-01-22

8.  Surgical resection of esophagogastric junction stromal tumor: How to protect the cardiac function.

Authors:  Guo-Liang Zheng; Bao Zhang; Yue Wang; Yong Liu; Hai-Tao Zhu; Yan Zhao; Zhi-Chao Zheng
Journal:  World J Gastroenterol       Date:  2021-03-07       Impact factor: 5.742

9.  Screening and Identifying Erosive Esophagitis in Children with Non-cardiac Chest Pain.

Authors:  Hye Won Park; You Jin Choi; Su Jin Jeong
Journal:  J Korean Med Sci       Date:  2016-01-14       Impact factor: 2.153

10.  Gastroesophageal reflux disease and its related factors among women of reproductive age: Korea Nurses' Health Study.

Authors:  Oksoo Kim; Hee Jung Jang; Sue Kim; Hea-Young Lee; Eunyoung Cho; Jung Eun Lee; Heeja Jung; Jiyoung Kim
Journal:  BMC Public Health       Date:  2018-09-21       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.